Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Por um escritor misterioso
Descrição
Multisystem inflammatory syndrome in children: another COVID-19 sequel, Cardiology in the Young
Frontiers Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland
Preventing Life-Threatening Blood Clots in Children with Serious Cases of COVID-19
Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021
Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China
Thrombotic Events Linked With Higher Mortality Among Pediatric Patients Hospitalized With COVID-19, MIS-C - Hematology Advisor
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Schmitz - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library
Frontiers Therapeutic Strategies for COVID-19 Lung Disease in Children
Post-SARS-CoV-2 Multisystemic Syndrome in the Paediatric Population of Pakistan: A Case Report - European Medical Journal
Post-SARS-CoV-2 Multisystemic Syndrome in the Paediatric Population of Pakistan: A Case Report - European Medical Journal
Thromboembolism in children with multisystem inflammatory syndrome: a literature review
Multi-system Inflammatory Syndrome in Children (MIS-C) News and Updates
Multisystem inflammatory syndrome in children: another COVID-19 sequel, Cardiology in the Young
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID -19 — COVID-NET, 14 States, March 2020–February 2022
Biomarker Changes in Pediatric Patients With COVID-19: A Retrospective Study from a Single Center Database
de
por adulto (o preço varia de acordo com o tamanho do grupo)
